9688 — Zai Lab Income Statement
0.000.00%
- HK$27.80bn
- HK$22.78bn
- $398.99m
Annual income statement for Zai Lab, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 49 | 144 | 215 | 267 | 399 |
Cost of Revenue | |||||
Gross Profit | 32.2 | 92.1 | 141 | 171 | 252 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 351 | 844 | 619 | 633 | 681 |
Operating Profit | -302 | -700 | -404 | -367 | -282 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -268 | -703 | -443 | -335 | -257 |
Provision for Income Taxes | |||||
Net Income After Taxes | -268 | -703 | -443 | -335 | -257 |
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -269 | -704 | -443 | -335 | -257 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -269 | -704 | -443 | -335 | -257 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.346 | -0.758 | -0.463 | -0.357 | -0.259 |